Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

547Citations
Citations of this article
221Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P = .01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P = .05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.

Cite

CITATION STYLE

APA

Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003). Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clinical Infectious Diseases, 36(11), 1418–1423. https://doi.org/10.1086/375057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free